VanEck Vectors Performance

BBH -- USA Etf

USD 127.68 1.56 0.01%

The entity has beta of 0.0027 which indicates as returns on market increase, VanEck Vectors returns are expected to increase less than the market. However during bear market, the loss on holding VanEck Vectors will be expected to be smaller as well. Although it is extremely important to respect VanEck Vectors Biotech current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting VanEck Vectors Biotech technical indicators you can presently evaluate if the expected return of 0.2345% will be sustainable into the future.

Horizon

30 Days Login to change

VanEck Vectors Biotech Relative Risk vs. Return Landscape

If you would invest 11,700 in VanEck Vectors Biotech ETF on December 22, 2018 and sell it today you would earn a total of 1,068 from holding VanEck Vectors Biotech ETF or generate 9.13% return on investment over 30 days. VanEck Vectors Biotech ETF is generating 0.2345% of daily returns assuming volatility of 2.1019% on return distribution over 30 days investment horizon. In other words, 19% of equities are less volatile than the company and above 96% of equities are expected to generate higher returns over the next 30 days.

Daily Expected Return (%)

Risk (%)

Considering 30-days investment horizon, VanEck Vectors is expected to generate 1.04 times more return on investment than the market. However, the company is 1.04 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The DOW is currently generating roughly 0.03 per unit of risk.

VanEck Vectors Market Risk Analysis

Sharpe Ratio = 0.1116

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns		BBH
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

VanEck Vectors Relative Performance Indicators

Estimated Market Risk

2.1

actual daily

19 %

of total potential

Expected Return

0.23

actual daily

4 %

of total potential

Risk-Adjusted Return

0.11

actual daily

7 %

of total potential

Based on monthly moving average VanEck Vectors is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Vectors by adding it to a well-diversified portfolio.

VanEck Vectors Performance Rating

VanEck Vectors Biotech ETF Risk Adjusted Performance Analysis

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in VanEck Vectors Biotech ETF are ranked lower than 7 (%) of all global equities and portfolios over the last 30 days.

View VanEck Vectors

VanEck Vectors Alerts

Equity Alerts and Improvement Suggestions

	On December 20, 2018 VanEck Vectors paid $ 5.537 per share dividend to its current shareholders
	The fund generated three year return of -4.0%
	VanEck Vectors Biotech holds 99.93% of its assets under management (AUM) in equities

VanEck Vectors Performance Indicators

VanEck Vectors Biotech Basic Price Performance Measures

Fifty Two Week Low	103.25
Fifty Two Week High	136.84

VanEck Vectors Dividends

VanEck Vectors Biotech Dividends Analysis

Check VanEck Vectors Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income

Check Dividends

Check also Trending Equities. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Search macroaxis.com